SI-2 (hydrochloride) Datasheet DC Chemicals
Target Home > Products > Featured products
Cat.No DC65483
Name SI-2 (hydrochloride)

Chemical Properties

CAS 1992052-49-9
Formula C15H16CLN5
MW 301.774041175842
Storage 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO

Biological activity

Description CAS NO.:1992052-49-9
Product Name:SI-2 (hydrochloride)
Synonyms:SI-2 (hydrochloride);1-Methyl-2-(2-(1-(pyridin-2-yl)ethylidene)hydrazineyl)-1H-benzo[d]imidazole hydrochloride;SI-2 hydrochloride;EPH 116 hydrochloride
EINEC:
Molecular Formula:C15H16CLN5
Molecular Weight:301.774041175842
Target: IC50:3-20 nM (breast cancer cell death)[1].
In Vivo SI-2 causes minimal acute cardiotoxicity based on a hERG channel blocking assay and an unappreciable chronic toxicity to major organs based on histological analyses[1]. SI-2 is a drug-like molecule and meets all of the criteria of Lipinski’s rule[1]. Animal Model: MDA-MB-468 breast cancer mouse model[1]. Dosage: 2 mg/kg. Administration: Twice daily for 5 weeks (Vehicle, PBS). Result: Significantly inhibit tumor growth. SRC-3 levels in SI-2–treated tumor tissues were significantly lower than the PBS treated control group. Animal Model: CD1 mice[1]. Dosage: 20 mg/kg (Pharmacokinetic Analysis). Administration: Intraperitoneal administration once. Result: T1/2 = 1 h, Cmax of 3.0 μM, and the time to reach the maximum plasma concentration tmax of 0.25 h. SI-2 only degrades slightly (less than 5%) at pH 1.6 and 3.0 within 6 h, and is stable in buffers with pH ≥ 5.
In Vitro SI-2 selectively reduce the transcriptional activities and the protein concentrations of SRC-3 in cells through direct physical interactions with SRC-3[1]. SI-2 selectively induces breast cancer cell death with IC50 values in the low nanomolar range (3-20 nM), but not affect normal cell viability[1]. SI-2 (100 nM) decreases cell motility, invasion, and tumor metastasis in MDAMB-468 cells[1]. Cell Viability Assay[1]. Cell Line: MDA-MB-468 cells. Concentration: 100 nM. Incubation Time: 12 hours. Result: Significantly reduced the motility of cancer cells. Western Blot Analysis[1]. Cell Line: MDAMB-468 cells. Concentration: 0-200 nM. Incubation Time: 24 hours. Result: Significantly reduced SRC-3 protein levels. Did not decrease the SRC-3 mRNA level. Western Blot Analysis[1]. Cell Line: Cancer cells. Concentration: 0-200 nM. Incubation Time: 24 hours. Result: Caused PARP cleavage.
Kinase Assay
Cell Assay
Animal Administration

References

[1]. Song X, et al. Development of potent small-molecule inhibitors to drug the undruggable steroid receptor coactivator-3. Proc Natl Acad Sci U S A. 2016 May 3;113(18):4970-5.
Return Policy
If you are in any way unsatisfied with your purchase, you may return any item(s) within 365 days of its original purchase date.
Please provide your Order Number in the email. We strive to reply to all email inquiries within one business day.
Tel: +86-21-58447131
Fax: +86-21-61642470

Email:
sales@dcchemicals.com
order@dcchemicals.com

Website:
www.dcchemicals.com